Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,053 JPY | -1.12% | -2.17% | -0.02% |
04-30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.02% | 41.63B | |
+33.43% | 700B | |
+27.55% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.70% | 236B | |
+6.35% | 202B | |
-9.04% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- European Medicines Agency Committee Backs Approval of Takeda's Fruquintinib to Treat Colorectal Cancer